高急性期虚血性脳卒中における経頭蓋直流電気刺激の安全性と実現可能性(DICAST-SF試験)
Matej Slovak1, David Kemlink1, Pavel Dusek1
1Department of Neurology and Center for Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
まとめ
陰極経頭蓋直流電気刺激(C-tDCS)は、急性虚血性脳卒中患者において安全かつ実現可能です。この神経保護法は良好な忍容性を示し、脳卒中治療のためのさらなる試験を支持します。
科学分野:
- 神経学
- 神経科学
- 医療機器
背景:
- 虚血性脳卒中では、超急性期における緊急の神経保護が必要です。
- 陰極経頭蓋直流電気刺激(C-tDCS)は、潜在的な神経保護介入です。
- 救済可能なペナンブラを有する脳卒中患者におけるC-tDCSの評価は重要です。
研究 の 目的:
- C-tDCSの安全性、忍容性、実現可能性を評価すること。
- 急性虚血性脳卒中におけるC-tDCSの潜在的な有効性を検討すること。
- 用量漸増試験においてC-tDCSパラメータを決定すること。
主な方法:
- 二重盲検、ランダム化、シャム対照、用量漸増試験(DICAST-SF)。
- 内頚動脈/中大脳動脈閉塞、24時間以内、救済可能なペナンブラを有する脳卒中患者を含める。
- 影響を受けた一次運動野に6つの用量階層でC-tDCSを適用する。
主要な成果:
- 活動群C-tDCS群では症候性頭蓋内出血(SICH)は発生しませんでした。
- C-tDCSは忍容性が高く、実現可能であり、ランダム化から刺激開始までの時間の中央値は8分でした。
- 無症候性頭蓋内出血(AICH)およびその他の有害事象は、活動群とシャム群で同等でした。
結論:
- C-tDCSは、超急性期虚血性脳卒中に対する安全で忍容性が高く、実現可能な治療法です。
- 本結果は、脳卒中有効性に関するより大規模な臨床試験におけるC-tDCSのさらなる調査を支持します。
- C-tDCSは、急性脳卒中管理における神経保護戦略として有望です。
関連する概念動画
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm
420
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
420
Clinical Trials
10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.5K
Guidelines and Strategies for Safe Computer Charting
2.7K
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
2.7K
Electrical Current
7.2K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
7.2K
Directing Effect of Substituents: meta-Directing Groups
6.0K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K


